These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 22626743)

  • 1. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study.
    De Simone A; Leoni L; Luzi M; Amellone C; Stabile G; La Rocca V; Capucci A; D'onofrio A; Ammendola E; Accardi F; Valsecchi S; Buja G
    Europace; 2015 Aug; 17(8):1267-75. PubMed ID: 25842271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
    Al-Khatib SM; Piccini JP; Knight D; Stewart M; Clapp-Channing N; Sanders GD
    J Cardiovasc Electrophysiol; 2010 May; 21(5):545-50. PubMed ID: 20021522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
    Varma N; Michalski J; Epstein AE; Schweikert R
    Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):428-36. PubMed ID: 20716717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
    Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
    Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively.
    Marzegalli M; Landolina M; Lunati M; Perego GB; Pappone A; Guenzati G; Campana C; Frigerio M; Parati G; Curnis A; Colangelo I; Valsecchi S
    Trials; 2009 Jun; 10():42. PubMed ID: 19538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study.
    Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G
    Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
    Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
    Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
    Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
    Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial.
    Zanaboni P; Landolina M; Marzegalli M; Lunati M; Perego GB; Guenzati G; Curnis A; Valsecchi S; Borghetti F; Borghi G; Masella C
    J Med Internet Res; 2013 May; 15(5):e106. PubMed ID: 23722666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital follow-up of implantable cardioverter defibrillator and pacemaker carriers: patients' inconvenience and points of view. A four-hospital Italian survey.
    Gramegna L; Tomasi C; Gasparini G; Scaboro G; Zanon F; Boaretto G; Tomei R; Tomasi L
    Europace; 2012 Mar; 14(3):345-50. PubMed ID: 22080472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of alert messages in the remote monitoring of implantable cardioverter defibrillators and pacemakers: an Italian single-region study.
    Folino AF; Chiusso F; Zanotto G; Vaccari D; Gasparini G; Megna A; Marras E; Mantovan R; Vaglio A; Boscolo G; Biancalana G; Leoni L; Iliceto S; Buja G
    Europace; 2011 Sep; 13(9):1281-91. PubMed ID: 21642369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial.
    Adamson PB; Gold MR; Bennett T; Bourge RC; Stevenson LW; Trupp R; Stromberg K; Wilkoff BL; Costanzo MR; Luby A; Aranda JM; Heywood JT; Baldwin HA; Aaron M; Smith A; Zile M
    Congest Heart Fail; 2011; 17(5):248-54. PubMed ID: 21906250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an Organizational Management Model of Remote Implantable Cardioverter-Defibrillator Monitoring Alerts.
    Guédon-Moreau L; Finat L; Boulé S; Wissocque L; Marquié C; Brigadeau F; Kouakam C; Mondésert B; Kacet S; Klug D; Lacroix D
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):403-12. PubMed ID: 26105725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the MONITOR-ICD study: a randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with Implantable Cardioverter Defibrillators.
    Zabel M; Müller-Riemenschneider F; Geller JC; Brachmann J; Kühlkamp V; Dissmann R; Reinhold T; Roll S; Lüthje L; Bode F; Eckardt L; Willich SN;
    Am Heart J; 2014 Oct; 168(4):430-7. PubMed ID: 25262251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
    Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
    Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial.
    Hindricks G; Elsner C; Piorkowski C; Taborsky M; Geller JC; Schumacher B; Bytesnik J; Kottkamp H
    Eur Heart J; 2014 Jan; 35(2):98-105. PubMed ID: 23868932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators.
    Theuns DA; Rivero-Ayerza M; Knops P; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S63-5. PubMed ID: 19250114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.